| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
NeuroOne Medical Tech (NASDAQ:NMTC) is set to give its latest quarterly earnings report on Tuesday, 2024-02-13. Here's what investors need to know before the announcement.
Analysts estimate that NeuroOne Medical Tech will report an earnings per share (EPS) of $-0.14.
NeuroOne Medical Tech bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Last quarter the company beat EPS by $0.04, which was followed by a 11.05% drop in the share price the next day.
Here's a look at NeuroOne Medical Tech's past performance and the resulting price change:
| Quarter | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|
| EPS Estimate | -0.17 | -0.2 | -0.20 | -0.11 |
| EPS Actual | -0.13 | -0.2 | -0.21 | -0.11 |
| Price Change % | -11.05% | -3.76% | 0.77% | 0.0% |
Shares of NeuroOne Medical Tech were trading at $1.45 as of February 09. Over the last 52-week period, shares are down 18.5%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.
To track all earnings releases for NeuroOne Medical Tech visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: NMTC
